MORC3 and calcinosis: This case underscores the need to consider autoimmune myositis in patients presenting with calcinosis cutis and ischemic changes, as recognition of anti-NXP2 dermatomyositis is essential for early diagnosis, multidisciplinary management, guidance of oncologic surveillance, and prevention of irreversible vascular outcomes.